Funding for this research was provided by:
Région Occitanie (14352)
Received: 30 August 2019
Accepted: 1 April 2020
First Online: 19 May 2020
Ethics approval and consent to participate
: All informed consents were signed by each patient.Ethics Committee / ANSM Approval prior to the beginning of the study (2014, inclusion period 2016–2018): CPP Sud Méditerranée, #ID-RCB:2014-A01752–45.International Clinical Trial Registration Number (ExternalRef removed): #NCT03721861.
: NA as all data are anonymized, informed consent includes the right to use anonymized data including videos for scientific publication.
: DG is shareholder of the NEURINNOV spin-off created in November 2018. LW is partially supported by NEURINNOV funds and was asked to help on data processing. However, the study was completed before NEURINNOV creation.